PharmaLegacy Laboratories (Shanghai) Co., Ltdis a Humanized mice,DMPKin one large multi-functional integrated modern enterprise,and devote the high-quality Rheumatoid arthritis Modelx2a38631n and first-class service for the masses of customers.

   

PharmaLegacy Laboratories (Shanghai) Co., Ltd is specialized in Business services,Medical service,Medical insurance since established in 10 years ago.So far,our company has established its branch companies in major cities throughout the country.Formed in Building 7, 388 Jialilue Road Zhangjiang High-Tech Park Pudong District Shanghai,Pudongxin District,City area,Shanghai,China as the center, the radiation sales system and service network.Details:Humanized mice are a robust in vivo platform for analyzing the safety and effectiveness of potential new drugs to modulate the immune system. Humanized mice are supreme in vivo models for long-term studies in the fields of immuno-oncology, infectious disease, and graft versus host disease. Humanized mouse model engrafted with cord blood-derived hematopoietic stem cells (HSC) develop a functional human immune system and display robust T-cell maturation and T-cell dependent inflammatory responses. Large cohorts of humanized mice are available for immediate delivery or to enroll in drug efficacy testing services.

   Adhering to the Sincere service, the pursuit of perfection spirit of enterprise, PharmaLegacy bases on long-term development, technology as the core, market-oriented, and constantly open up new areas, undertaking to provide fast, high-quality service for the vast numbers of users. For further information about PharmaLegacyOsteoarthritis Model, please visit our official website: www.pharmalegacy.com.

PharmaLegacy Laboratories is a leading speciality pharmacology Contract Research Organization located in Shanghai Zhangjiang High-Tech Park, China. PharmaLegacy is equipped with a world-class facility, working to international pharmaceutical industrial standards. PharmaLegacy provides preclinical in vivo pharmacology efficacy services as well a therapeutic antibody discovery service program. Our state-of-the-art platforms include:· Pioneering work using CD34+ humanized mice that carry a human immune system, to test biologics for immuno-oncology therapeutic efficacy· An NHP platform for therapeutic biologics testing in a variety of immune diseases · An advanced antibody discovery platform based on single B cell antibody sequencing · An internationally recognized Bone/Orthopaedics platform to test both hard tissue disease therapeutic candidates and medical devicesPharmaLegacy offers a full range of preclinical pharmacology services for evaluating pharmacological effects of drug candidates in the areas of inflammation/auto-Immune diseases, lung injury, liver/metabolic diseases and oncology. Our NHP platform and CD34+ humanized mice models have helped dozens of clients with IND filings